Clinical Trial Update: Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell Carcinoma [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating surgery combined with rAd-p53 gene therapy for advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gendicine (recombinant adenovirus p53 gene therapy)

Snippet

Sponsor: Shenzhen SiBiono GeneTech Co.,Ltd | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN